Glandore's Michael Kelly increases his stake in Poolbeg Pharma – The Irish Times
Most recent acquisition makes managing director the company’s second-largest shareholder after founder Cathal Friel
Stay updated with breaking news from David Allmond. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Most recent acquisition makes managing director the company’s second-largest shareholder after founder Cathal Friel
Poolbeg Pharma PLC Announces Option Agreement to Acquire Orphan Drug ...
Novacyt SA on Thursday said it has promoted Executive Director Lyn Rees to chief executive officer, as acting CEO James McCarthy plans to step down from his role on May 1. This comes after CEO David...
Businessman Cathal Friel has become executive chairman of Poolbeg Pharma, the same job he had at Open Orphan (now hVivo) as that firm was developed.
LONDON, UK / ACCESSWIRE / February 15, 2024 / Poolbeg Pharma (AIM:POLB, OTCQB:POLBF, "Poolbeg" or the "Company"), a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, announces a change of Board ro...